ArticleMikrochimica acta2025
Dual enzyme-mimetic activity of graphene oxide framework encapsulated copper-palladium bimetallic nanoparticles for uricase-free colorimetric detection of uric acid.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of Single-Atom Nanozymes in the Detection of Small Biomolecules: A Review.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A novel CuPd@GOF nanocomposite is introduced, where copper and palladium nanoparticles (∼2 nm) are encapsulated within a three-dimensional graphene oxide framework (GOF), enabling superior catalytic performance. The rigid GOF structure ensures high nanoparticle dispersion, Maximizing atom utilization and catalytic efficiency. Additionally, Cu incorporation enhances activity through Fenton-like catalysis while reducing Material costs. The nanocomposite possesses a 2.72 eV bandgap, facilitating light harvesting ability for photocatalysis. CuPd@GOF exhibits dual enzyme-mimetic activities: a superior peroxidase-mimic activity, surpassing monometallic Cu@GOF and Pd@GOF, and an oxidase-mimic activity under external light irradiation. The peroxidase-mimic activity of this novel nanocomposite was exploited for uricase-free colorimetric detection of uric acid (UA), a key biomarker for gout and kidney disorders. The colorimetric assay utilizes Cu-mediated urate complexation and π-π interactions for enzyme-free detection, achieving a detection Limit of 12.62 µM with a broad linear range (5-100 µM) within 10 min. The method exhibits good selectivity against biological interferents and was successfully validated using fetal bovine serum, demonstrating its potential for biomedical applications.
Indexed as
Identifiers
40993432What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.